209P The management of brain disease (BD) in ALK-rearranged non-small cell lung cancer (ALK NSCLC): Can systemic treatment delay the initiation of local treatments? Experience of t... by Huertas, R. Martin, Garcia, I. Ciscar, Serrano, C. Saavedra, Domingo, J.J. Serrano, de la Fuente, E. Corral, Castillo, J.J. Soto, Rueda, A. Gomez, Olmedo Garcia, M.E., Lopez, P. Garrido

Get full text

Impact on survival outcomes of poorly controlled hypertension after initiation of abiraterone/enzalutamide in patients with metastatic Castration-Resistant Prostate Cancer (mCRPC) by Pozas, J., San Roman Gil, M., Orejana Martin, I., Mata Alcaraz, M., Artiles Medina, A., Molina Cerrillo, J., Gajate Borau, P., Reguera Puertas, P., Serrano Domingo, J.J., Albarrán Fernández, V., Rodríguez Patrón, R., Burgos Revilla, J., Carrato Mena, A., Álvarez Rodríguez, S., Alonso Gordoa, T.

Get full text

The management of brain disease (BD) in ALK-rearranged non-small cell lung cancer (ALK NSCLC): Can systemic treatment delay the initiation of local treatments? Experience of the Ra... by Huertas, Martin R, Garcia, Ciscar I, Serrano, Saavedra C, Domingo, Serrano J.J, de la Fuente, Corral E, Castillo, Soto J.J, Rueda, Gomez A, Garcia, Olmedo M.E, Lopez, Garrido P

Get full text

Incidence of urological complications in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with first line abiraterone and enzalutamide by Lorca Alvaro, J., Serrano Domingo, J.J., Álvarez Rodriguez, S., Alonso Gordoa, T., López Campos, F., Rodriguez-Patrón, R., Gajate Borau, P., Brasero Burgos, J., Laso Garcia, I., Carrato Mena, A., Burgos Revilla, F.J.

Get full text

Survival impact of the management of medical and urological complications during treatment with 1st line abiraterone (A) or enzalutamide (E) in patients with metastatic castration-... by Serrano Domingo, J.J., Lorca Alvaro, J., Avarez Rodriguez, S., Gajate Borau, P., Alonso Gordoa, T., Barquin Garcia, A., Molina, J., Martinez-Saez, O., Martin Huertas, R., Corral De La Fuente, E., Rodriguez-Patrón, R., Burgos Revilla, F.J., Carrato Mena, A.

Get full text

P053 - Incidence of urological complications in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with first line abiraterone and enzalutamide by Lorca Alvaro, J., Serrano Domingo, J.J., Álvarez Rodriguez, S., Alonso Gordoa, T., López Campos, F., Rodriguez-Patrón, R., Gajate Borau, P., Brasero Burgos, J., Laso Garcia, I., Carrato Mena, A., Burgos Revilla, F.J.

Get full text

P058 - Survival impact of the management of medical and urological complications during treatment with 1st line abiraterone (A) or enzalutamide (E) in patients with metastatic cast... by Serrano Domingo, J.J., Lorca Alvaro, J., Avarez Rodriguez, S., Gajate Borau, P., Alonso Gordoa, T., Barquin Garcia, A., Molina, J., Martinez-Saez, O., Martin Huertas, R., Corral De La Fuente, E., Rodriguez-Patrón, R., Burgos Revilla, F.J., Carrato Mena, A.

Get full text